Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07169227
PHASE4

Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain

Sponsor: Baskent University

View on ClinicalTrials.gov

Summary

Propofol and rocuronium may cause pain during intravenous injection. Various pharmacological agents are used to reduce the incidence and severity of injection pain. Among the most commonly used agents for this purpose are lidocaine, various opioids, ketamine, paracetamol, and dexmedetomidine. The aim of this study was to evaluate the comparative effect of intravenous dexmedetomidine and paracetamol versus lidocaine in preventing propofol- and rocuronium-induced pain during anesthesia induction.

Official title: The Comparison of the Efficacy of Lidocaine, Paracetamol, and Dexmedetomidine in Preventing Rocuronium Injection Pain

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

170

Start Date

2025-09

Completion Date

2025-10

Last Updated

2025-09-11

Healthy Volunteers

Yes

Interventions

DRUG

Lidocaine %2 ampoule

Patients who were administered 40 mg lidocaine.

DRUG

Dexmedetomidine

Patients who were administered 0.25 mg/kg dexmedetomidine.

DRUG

paracetamol

Patients who were administered 50 mg paracetamol.

Locations (1)

Baskent University

Adana, Adana, Turkey (Türkiye)